MiMedx Group, Inc. ( MDXG) - Stock Earnings
MDXG Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 16.7 million USD | 113.7 million USD |
| 2025Q4 | 15.2 million USD | 118.1 million USD |
| 2026Q1 | -10.9 million USD | 59.0 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MDXG Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 67.4 million USD | 321.5 million USD |
| 2024 | 42.4 million USD | 348.9 million USD |
| 2025 | 48.6 million USD | 418.6 million USD |
| 2026 Est. | — | — |
MDXG
Price: $3.68
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.20 USD
P/E Ratio: 18.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 527584
Ebitda: 10.3 millionMarket Capitalization: 557.1 million